Photo from wikipedia
Infection remains one of the most common transplant‐related causes of death in patients undergoing transplantation. Secondary hypogammaglobulinemia (HGG) as a component of immune suppression and deficiency is associated with both… Click to show full abstract
Infection remains one of the most common transplant‐related causes of death in patients undergoing transplantation. Secondary hypogammaglobulinemia (HGG) as a component of immune suppression and deficiency is associated with both solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT). Available data and clinical experience for the supplementation of immunoglobulin (Ig) in these patients is conflicting, and differing clinical opinion accounts for non‐uniform practice in the use of Ig treatment. We aimed to survey lead transplant practitioners for current practice around polyvalent Ig use in post‐transplant recipients across Canada.
Journal Title: Transplant Infectious Disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!